IRON Disc Medicine, Inc.
61.18USD-0.76%Mkt Cap: 2.35B $P/E: —1d ago
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hemato…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.35B USD
Enterprise Value1.71B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-212.18M USD
Revenue/Share—
Last Price61.18 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees165
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.71
PEG—
EV/EBITDA-6.38
EV/Revenue—
P/S—
P/B3.67
EPS (TTM)-6.58
EPS (Forward)-7.08
52W Range
40.0036% of range99.50
52W High99.50 USD
52W Low40.00 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.68%
ROA-26.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-180.39M USD
CapEx (TTM)933.00K USD
FCF Margin—
FCF Yield-5.00%
Net Debt-656.88M USD
Net Debt/EBITDA2.45
Balance Sheet
Debt/Equity0.04
Current Ratio24.14
Quick Ratio23.64
Book Value/Sh16.80 USD
Cash/Share18.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateDec 30, 2022
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)103.17 USD
Upside (mean)+68.6%
Target Range83.00 USD – 128.00 USD
83.00+68.6% to mean128.00
# Analysts12
Ownership
Shares Out.38.39M
Float32.91M
Insiders7.84%
Institutions114.13%
Short Interest
Short Ratio14.7d
Short % Float21.89%
Short % Out.18.77%
Shares Short7.21M
Short (prev mo.)7.34M
Technical
SMA 5074.67 (-18.1%)
SMA 20071.67 (-14.6%)
Beta2.11
S&P 52W Chg16.45%
Avg Vol (30d)563.26K
Avg Vol (10d)572.43K
Technical Indicators
RSI (14)26.0
MACD-3.6191
MACD Signal-3.2219
MACD Hist.-0.3972
BB Upper76.19 USD
BB Middle67.43 USD
BB Lower58.67 USD
BB Width25.98%
ATR (14)2.805 USD
Vol Ratio (20d)0.88x